van den Boom Esther 4
4 · Tyra Biosciences, Inc. · Filed Sep 8, 2022
Insider Transaction Report
Form 4
van den Boom Esther
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-06+105,000→ 105,000 totalExercise: $7.14Exp: 2032-09-05→ Common Stock (105,000 underlying) - Award
Common Stock
2022-03-15$8.53/sh+1,800$15,346→ 120,445 total - Award
Stock Option (Right to Buy)
2022-09-06+89,054→ 89,054 totalExercise: $7.14Exp: 2032-09-05→ Common Stock (89,054 underlying)
Holdings
- 118,645(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.
- [F3]1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
- [F4]1/36th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.